Deutsche Bank AG Boosts Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Deutsche Bank AG grew its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 11,464.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 650,128 shares of the company’s stock after purchasing an additional 644,506 shares during the period. Deutsche Bank AG owned approximately 0.70% of Acadia Healthcare worth $25,778,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Wellington Management Group LLP grew its position in Acadia Healthcare by 0.7% during the fourth quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company’s stock worth $465,283,000 after buying an additional 76,490 shares in the last quarter. FMR LLC grew its holdings in shares of Acadia Healthcare by 257.9% during the fourth quarter. FMR LLC now owns 6,230,631 shares of the company’s stock worth $247,045,000 after purchasing an additional 4,489,681 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Acadia Healthcare by 18.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company’s stock worth $126,189,000 after purchasing an additional 486,395 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after purchasing an additional 454,044 shares in the last quarter. Finally, Stephens Investment Management Group LLC lifted its position in Acadia Healthcare by 24.9% during the fourth quarter. Stephens Investment Management Group LLC now owns 1,475,166 shares of the company’s stock valued at $58,490,000 after purchasing an additional 294,210 shares during the last quarter.

Acadia Healthcare Price Performance

ACHC opened at $25.72 on Thursday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The stock’s 50 day simple moving average is $26.34 and its 200 day simple moving average is $36.01. The firm has a market cap of $2.37 billion, a price-to-earnings ratio of 8.43, a PEG ratio of 1.46 and a beta of 1.01. Acadia Healthcare Company, Inc. has a 1 year low of $20.36 and a 1 year high of $82.41.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.05. The firm had revenue of $770.51 million for the quarter, compared to analysts’ expectations of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business’s revenue was up .3% on a year-over-year basis. During the same quarter last year, the business earned $0.84 earnings per share. As a group, analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Guggenheim started coverage on shares of Acadia Healthcare in a research report on Wednesday, April 9th. They set a “buy” rating and a $36.00 price objective on the stock. Barclays lowered their price target on Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Royal Bank of Canada cut their price objective on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a report on Monday, March 3rd. Mizuho decreased their price objective on Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating on the stock in a report on Wednesday. Finally, Bank of America cut their target price on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $47.94.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.